| Literature DB >> 35521816 |
Kirsten Davidse1, Anneloes van Staa2, Wanda Geilvoet1, Judith P van Eck3, Karlijn Pellikaan1, Janneke Baan1, Anita C S Hokken-Koelega3,4,5, Erica L T van den Akker3, Theo Sas3,6, Sabine E Hannema3,7, Aart Jan van der Lely1, Laura C G de Graaff1,4.
Abstract
Introduction: Transition from paediatric to adult endocrinology can be challenging for adolescents, their families and healthcare professionals. Previous studies have shown that up to 25% of young adults with endocrine disorders are lost to follow-up after moving out of paediatric care. This poses a health risk for young adults, which can lead to serious and expensive medical acute and long-term complications.Entities:
Keywords: adolescent; endocrinology; paediatrics; transition to adult care; young adult
Year: 2022 PMID: 35521816 PMCID: PMC9175586 DOI: 10.1530/EC-22-0025
Source DB: PubMed Journal: Endocr Connect ISSN: 2049-3614 Impact factor: 3.221
Figure 1Inclusion and exclusion process.
Diagnoses of included patients (n = 180).
| Adrenal | Thyroid | Gonads | Pituitary | Other | |||||
|---|---|---|---|---|---|---|---|---|---|
| Addison’s disease | 8 | Graves’ disease | 6 | Oligo-/amenorrhoea | 4 | Congenital pituitary anomaly | 15 | Polyglandular syndrome | 1 |
| 17a-OH hydroxylase deficiency | 1 | Congenital hypothyroidism | 6 | Complete androgen insensitivity syndrome (CAIS) | 4 | (Pan) hypopituitarism | 4 | Fanconi anaemia | 2 |
| Hyperandrogenism | 1 | Multinodular goitre | 2 | Polycystic ovary syndrome (PCOS) | 9 | Central adrenal insufficiency | 1 | Follow-up after (chemo-)radiation | 25 |
| Congenital adrenal hyperplasia (CAH) salt loosing type | 9 | Hemi- or total thyroidectomy | 3 | Sex chromosome mosaicism | 2 | Diabetes insipidus | 4 | Hypophosphatemic rickets | 2 |
| Congenital adrenal hyperplasia (CAH), non-salt loosing type | 4 | Hashimoto thyroiditis | 2 | Hypogonadotropic hypogonadism | 3 | Growth hormone deficiency | 2 | McCune-Albright syndrome | 1 |
| 1 | Toxic thyroid adenoma | 1 | Kallmann syndrome | 1 | Prolactinoma | 4 | Multiple endocrine neoplasia syndrome type 2A | 4 | |
| Ovotesticular disorder of sex development | 1 | Childhood-onset craniopharyngioma | 6 | Genetic obesity | 4 | ||||
| Partial androgen insensitivity syndrome (PAIS) | 1 | Septo-optical dysplasia | 2 | Childhood-onset osteopenia | 1 | ||||
| Premature ovarian failure | 2 | X-linked osteoporosis | 2 | ||||||
| Klinefelter syndrome | 5 | Von Hippel-Lindau disease | 1 | ||||||
| Turner syndrome | 19 | ||||||||
| Vanishing testes | 2 | ||||||||
| XXYY syndrome | 1 | ||||||||
| 17-beta-HSD-deficiency | 1 | ||||||||
| Total | 24 | 20 | 55 | 38 | 43 |
Transition success indicators according to gender and age of participants.
| TSI 1 | TSI 2 | TSI 3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Present at first AC appointment | Not present at first AC appointment | No missed AC consultations after first appointment | One or two missed AC consultations after first appointment | More than two missed AC consultations after first appointment | Lost to follow-up | No ER visits or hospital admissions after transfer | More than two emergency room visits /hospital admissions after transfer | ||||
| Gender | (gender) 0.45 | ||||||||||
| Males | 40 | 11 | 27 | 9 | 2 | 13 | 51 | 0 | |||
| Females | 58 | 22 | 52 | 5 | 3 | 20 | 79 | 1 | |||
| Total | 98 | 33 | 79 | 14 | 5 | 33 | 130 | 1 | |||
| Age at transfer to AC | |||||||||||
| <16 | 2 | 3 | 1 | 0 | 0 | 4 | 5 | 0 | |||
| 16–18 | 76 | 22 | 26 | 2 | 3 | 14 | 45 | 0 | |||
| >18 | 20 | 8 | 52 | 12 | 2 | 15 | 80 | 1 | |||
| Total | 98 | 33 | 79 | 14 | 5 | 33 | 130 | 1 | |||
Correlation between TSI 1 and 2: P < 0,001, correlation between TSI 1 and 3: P = 0,80, correlation between TSI 2 and 3: P = 0,64.
Diagnoses of patients who dropped out (n = 33).
| Adrenal | Thyroid | Gonads | Pituitary | Other | Total | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Hyperandrogenism | 1 | Multinodular goitre | 1 | Oligo-/amenorrhoea | 3 | Congenital abnormality of the pituitary | 1 | Follow-up after chemotherapy/irradiation chemoradiation | 9 | |
| Hashimoto thyroiditis | 1 | Polycystic ovary syndrome (PCOS) | 3 | (Pan)Hypopituitarism | 1 | Genetic obesity | 2 | |||
| Ovotesticular disorder of sex development | 1 | Childhood-onset craniopharyngioma | 1 | |||||||
| Partial androgen insensitivity syndrome (PAIS) | 1 | |||||||||
| Klinefelter syndrome | 4 | |||||||||
| Turner syndrome | 3 | |||||||||
| 17-beta-HSD-deficiency | 1 | |||||||||
| Total | 1 | 2 | 16 | 3 | 11 | 33 |
Figure 2Medical diagnosis for patients who successfully made the transfer to adult endocrine care (A) and for patients who dropped out (B).